Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 3, 2003, Pages 580-586

  Fiset, Pierre Olivier ^a   Soussi Gounni, Abdelilah ^a   Christodoulopoulos, Pota ^a   Tulic, Meri ^a   Sobol, Steven E ^a   Frenkiel, Saul ^b   Lavigne, François ^c   Lamkhioued, Bouchaib ^c   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

Allergy; Antisense oligonucleotides; Cytokines; Immunomodulation; Nasal mucosa

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; PHOSPHOROTHIOIC ACID; RAGWEED ANTIGEN;

ALLERGIC REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NOSE MUCOSA; PRIORITY JOURNAL; RAGWEED; TH2 CELL;

EID: 0037342980     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.179     Document Type: Article

References (29)

1. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL. IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. J Immunol 1992;148:3820-9.
2. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
3. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-86.
4. Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, et al. A novel human CC chemokine. eotaxin-3, which is expressed in IL-4- stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 1999;163:1602-10.
5. Oettgen HC, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001;107:429-40.
6. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107:963-70.
7. Molet S, Ramos-Barbon D, Martin JG, Hamid Q. Adoptively transferred late allergic response is inhibited by IL-4, but not IL-5, antisense oligonucleotide. J Allergy Clin Immunol 1999;104:205-14.
8. Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Muro S, et al. Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa alter ex vivo allergen exposure. J Allergy Clin Immunol 2000;106:46-52.
9. Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A, et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000;164:1538-45.
10. Nakamura Y, Christodoulopoulos P, Cameron L, Wright E, Lavigne F, Toda M, et al. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J Allergy Clin Immunol 2000;105:1146-52.
11. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27:2899-906.
12. Vinogradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 2002;54:135-47.
13. Crooke ST. Molecular mechanisms of action of antisense drugs. Biochim Biophys Acta 1999;1489:31-44.
14. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
15. Krieg AM. Immune effects and mechanisms of action of CpG motifs. Vaccine 2000;19:618-22.
16. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
17. Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ. Toll-like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol 2002;71:538-44.
18. Parronchi P, Brugnolo F, Annunziato F, Manuelli C, Sampognaro S, Mavilia C, et al. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999;163:5946-53.
19. Baek KH, Ha SJ, Sung YC. A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages. J Immunol 2001;167:2847-54.
20. Xu L, Gorham B, Li SC, Bottaro A, Alt FW, Rothman P. Replacement of germ-line epsilon promoter by gene targeting alters control of immunoglobulin heavy chain class switching. Proc Natl Acad Sci U S A 1993;90:3705-9.
21. Lorenz M, Jung S, Radbruch A. Switch transcripts in immunoglobulin class switching. Science 1995;267:1825-8.
22. Jabara HH, Fu SM, Geha RS. Vercelli D. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990;172:1861-4.
23. Zhang K, Clark EA, Saxon A. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol 1991;146:1836-42.
24. Xu L, Rothman P. IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. Int Immunol 1994;6:515-21.
25. Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
26. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
27. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schruder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-8.
28. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88.
29. Miyamasu M, Yamaguchi M, Nakajima T, Misaki Y, Morita Y, Matsushima K, et al. Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro. Int Immunol 1999;11:1001-4.